The IMID Forum

The IMID Forum

Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.

Den här podcasten är hämtad från ett öppet RSS-flöde och publiceras inte av Podme. Den kan innehålla reklam.

Avsnitt(416)

Discussing AxSpA: Risk of Uveitis with Different bDMARDs & PROs following Secukinumab Treatment

Discussing AxSpA: Risk of Uveitis with Different bDMARDs & PROs following Secukinumab Treatment

Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month Dr Sofia Ramiro is joined by Professors Hideto Kameda, Atul Deodhar and Xenofon Barali...

12 Aug 202432min

Discussing RA: March 2024

Discussing RA: March 2024

Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest information and data in rheumatology. In this episode, he discusses ...

12 Aug 20248min

Discussing PsA: Long-term safety of ixekizumab & bimekizumab treatment in a TNFi-IR population

Discussing PsA: Long-term safety of ixekizumab & bimekizumab treatment in a TNFi-IR population

Join Professors Peter Nash, Philip Mease, Frank Behrens, and Laura Coates as they discuss the top publications in the world of PsA. They discuss two highly relevant topics in the field, including the ...

12 Aug 202438min

Discussing AxSpA: Secukinumab retention over time & sacroiliac joint improvements between DMARDs

Discussing AxSpA: Secukinumab retention over time & sacroiliac joint improvements between DMARDs

Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month Dr Sofia Ramiro is joined by Professors Hideto Kameda and Atul Deodhar to discuss the ...

12 Aug 202433min

Discussing PsA: 2023 EULAR recommendations and improvements in PROs with deucravacitinib

Discussing PsA: 2023 EULAR recommendations and improvements in PROs with deucravacitinib

Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, they focus on the updated 2023 EULAR recommendations for PsA and the im...

12 Aug 202428min

Discussing AxSpA: Long-term etanercept response & real-world effectiveness of tofacitinib & adalimumab

Discussing AxSpA: Long-term etanercept response & real-world effectiveness of tofacitinib & adalimumab

Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month, Dr Sofia Ramiro is joined by Professors Hideto Kameda, Atul Deodhar and Xenofon Baral...

12 Aug 202429min

IMID Author Interview: Dr Blanca Hernández-Cruz, 2024

IMID Author Interview: Dr Blanca Hernández-Cruz, 2024

Join Professor Peter Nash from the Griffith University in Brisbane, and Blanca Hernández-Cruz, a rheumatologist at Virgen Macarena University Hospital in Seville, as they discuss her recent paper ‘Jan...

12 Aug 202433min

Discussing PsA: Bimekizumab therapy in PsA

Discussing PsA: Bimekizumab therapy in PsA

Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, they focus on the latest publication by Su, et al. and discuss the late...

12 Aug 202429min

Populärt inom Utbildning

det-skaver
historiepodden-se
rss-bara-en-till-om-beroende-medberoende
nu-blir-det-historia
not-fanny-anymore
harrisons-dramatiska-historia
rss-viktmedicinpodden
allt-du-velat-veta
johannes-hansen-podcast
roda-vita-rosen
i-vantan-pa-katastrofen
rikatillsammans-om-privatekonomi-rikedom-i-livet
sektledare
rss-basta-livet
rss-max-tant-med-max-villman
rss-traningsklubben
sa-in-i-sjalen
kan-jag-sa-kan-du-podden
sex-pa-riktigt-med-marika-smith
rss-okrystat